nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—colon cancer	0.393	1	CbGaD
Trazodone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.058	0.145	CbGbCtD
Trazodone—CYP3A7—Irinotecan—colon cancer	0.058	0.145	CbGbCtD
Trazodone—CYP3A7—Vincristine—colon cancer	0.0507	0.127	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0507	0.127	CbGbCtD
Trazodone—CYP3A5—Irinotecan—colon cancer	0.0435	0.109	CbGbCtD
Trazodone—CYP3A5—Vincristine—colon cancer	0.038	0.0954	CbGbCtD
Trazodone—ABCB1—Irinotecan—colon cancer	0.0283	0.071	CbGbCtD
Trazodone—ABCB1—Vincristine—colon cancer	0.0247	0.0621	CbGbCtD
Trazodone—CYP3A4—Irinotecan—colon cancer	0.017	0.0425	CbGbCtD
Trazodone—ABCB1—Methotrexate—colon cancer	0.015	0.0376	CbGbCtD
Trazodone—CYP3A4—Vincristine—colon cancer	0.0148	0.0372	CbGbCtD
Trazodone—ORM1—bile—colon cancer	0.00958	0.177	CbGeAlD
Trazodone—HTR2A—myenteric nerve plexus—colon cancer	0.00623	0.115	CbGeAlD
Trazodone—HTR2A—vein—colon cancer	0.00402	0.0744	CbGeAlD
Trazodone—ORM1—gall bladder—colon cancer	0.00266	0.0493	CbGeAlD
Trazodone—HTR2A—endothelium—colon cancer	0.00138	0.0256	CbGeAlD
Trazodone—HTR2A—blood vessel—colon cancer	0.00127	0.0236	CbGeAlD
Trazodone—CYP3A7—liver—colon cancer	0.00123	0.0228	CbGeAlD
Trazodone—HTR2B—smooth muscle tissue—colon cancer	0.00112	0.0207	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—liver—colon cancer	0.00105	0.0194	CbGeAlD
Trazodone—HTR1A—renal system—colon cancer	0.000965	0.0179	CbGeAlD
Trazodone—ORM1—bone marrow—colon cancer	0.000965	0.0179	CbGeAlD
Trazodone—ADRA1A—epithelium—colon cancer	0.000959	0.0178	CbGeAlD
Trazodone—SLC6A4—digestive system—colon cancer	0.000892	0.0165	CbGeAlD
Trazodone—ADRA1A—renal system—colon cancer	0.00089	0.0165	CbGeAlD
Trazodone—HTR2B—digestive system—colon cancer	0.000884	0.0164	CbGeAlD
Trazodone—ABCB1—blood vessel—colon cancer	0.000835	0.0155	CbGeAlD
Trazodone—HTR2B—vagina—colon cancer	0.00078	0.0145	CbGeAlD
Trazodone—ORM1—liver—colon cancer	0.00078	0.0144	CbGeAlD
Trazodone—HTR2A—embryo—colon cancer	0.00076	0.0141	CbGeAlD
Trazodone—HRH1—epithelium—colon cancer	0.000743	0.0138	CbGeAlD
Trazodone—ADRA1A—lymphoid tissue—colon cancer	0.000739	0.0137	CbGeAlD
Trazodone—HRH1—smooth muscle tissue—colon cancer	0.000716	0.0133	CbGeAlD
Trazodone—CYP3A5—renal system—colon cancer	0.00071	0.0131	CbGeAlD
Trazodone—HTR2A—epithelium—colon cancer	0.00062	0.0115	CbGeAlD
Trazodone—ORM1—lymph node—colon cancer	0.000598	0.0111	CbGeAlD
Trazodone—HTR2A—smooth muscle tissue—colon cancer	0.000598	0.0111	CbGeAlD
Trazodone—CYP3A5—digestive system—colon cancer	0.000582	0.0108	CbGeAlD
Trazodone—HTR2A—renal system—colon cancer	0.000575	0.0107	CbGeAlD
Trazodone—HRH1—digestive system—colon cancer	0.000565	0.0105	CbGeAlD
Trazodone—ADRA1A—liver—colon cancer	0.000544	0.0101	CbGeAlD
Trazodone—Deafness—Capecitabine—colon cancer	0.000534	0.00349	CcSEcCtD
Trazodone—CYP3A4—renal system—colon cancer	0.000533	0.00986	CbGeAlD
Trazodone—Eye pain—Capecitabine—colon cancer	0.000529	0.00345	CcSEcCtD
Trazodone—Haemolytic anaemia—Capecitabine—colon cancer	0.000529	0.00345	CcSEcCtD
Trazodone—Sweating—Irinotecan—colon cancer	0.000527	0.00344	CcSEcCtD
Trazodone—CYP2D6—renal system—colon cancer	0.000524	0.00971	CbGeAlD
Trazodone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000519	0.00339	CcSEcCtD
Trazodone—Dysarthria—Methotrexate—colon cancer	0.000518	0.00338	CcSEcCtD
Trazodone—Myocardial infarction—Fluorouracil—colon cancer	0.000516	0.00337	CcSEcCtD
Trazodone—Libido decreased—Capecitabine—colon cancer	0.000515	0.00336	CcSEcCtD
Trazodone—CYP3A5—vagina—colon cancer	0.000514	0.00952	CbGeAlD
Trazodone—Increased appetite—Capecitabine—colon cancer	0.000508	0.00332	CcSEcCtD
Trazodone—Amnesia—Capecitabine—colon cancer	0.000508	0.00332	CcSEcCtD
Trazodone—HTR2B—lymph node—colon cancer	0.000505	0.00935	CbGeAlD
Trazodone—Hallucination—Vincristine—colon cancer	0.000504	0.00329	CcSEcCtD
Trazodone—Hypoaesthesia—Vincristine—colon cancer	0.000504	0.00329	CcSEcCtD
Trazodone—Atrial fibrillation—Capecitabine—colon cancer	0.000504	0.00329	CcSEcCtD
Trazodone—Bradycardia—Irinotecan—colon cancer	0.000503	0.00328	CcSEcCtD
Trazodone—Vasculitis—Methotrexate—colon cancer	0.000502	0.00328	CcSEcCtD
Trazodone—HRH1—vagina—colon cancer	0.000499	0.00924	CbGeAlD
Trazodone—ABCB1—embryo—colon cancer	0.000498	0.00923	CbGeAlD
Trazodone—ADRA2A—vagina—colon cancer	0.00049	0.00908	CbGeAlD
Trazodone—Lethargy—Capecitabine—colon cancer	0.000487	0.00318	CcSEcCtD
Trazodone—Cerebrovascular accident—Capecitabine—colon cancer	0.000487	0.00318	CcSEcCtD
Trazodone—Hyponatraemia—Capecitabine—colon cancer	0.00048	0.00313	CcSEcCtD
Trazodone—Diplopia—Capecitabine—colon cancer	0.000478	0.00312	CcSEcCtD
Trazodone—Visual impairment—Irinotecan—colon cancer	0.000476	0.00311	CcSEcCtD
Trazodone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000474	0.00309	CcSEcCtD
Trazodone—Depressed level of consciousness—Methotrexate—colon cancer	0.000473	0.00309	CcSEcCtD
Trazodone—HTR2A—digestive system—colon cancer	0.000472	0.00874	CbGeAlD
Trazodone—Hypoaesthesia—Fluorouracil—colon cancer	0.00047	0.00307	CcSEcCtD
Trazodone—Migraine—Capecitabine—colon cancer	0.00047	0.00307	CcSEcCtD
Trazodone—Flushing—Irinotecan—colon cancer	0.000458	0.00299	CcSEcCtD
Trazodone—Cardiac arrest—Capecitabine—colon cancer	0.000454	0.00296	CcSEcCtD
Trazodone—Urinary retention—Capecitabine—colon cancer	0.000454	0.00296	CcSEcCtD
Trazodone—Ataxia—Capecitabine—colon cancer	0.000449	0.00293	CcSEcCtD
Trazodone—Alopecia—Vincristine—colon cancer	0.000448	0.00292	CcSEcCtD
Trazodone—Chills—Irinotecan—colon cancer	0.000443	0.00289	CcSEcCtD
Trazodone—Bladder pain—Methotrexate—colon cancer	0.000443	0.00289	CcSEcCtD
Trazodone—Arrhythmia—Irinotecan—colon cancer	0.000441	0.00288	CcSEcCtD
Trazodone—CYP3A4—digestive system—colon cancer	0.000437	0.00809	CbGeAlD
Trazodone—Alopecia—Irinotecan—colon cancer	0.000436	0.00285	CcSEcCtD
Trazodone—Orthostatic hypotension—Capecitabine—colon cancer	0.000436	0.00285	CcSEcCtD
Trazodone—CYP3A5—liver—colon cancer	0.000434	0.00803	CbGeAlD
Trazodone—CYP2D6—digestive system—colon cancer	0.00043	0.00796	CbGeAlD
Trazodone—Back pain—Vincristine—colon cancer	0.000427	0.00279	CcSEcCtD
Trazodone—Flatulence—Irinotecan—colon cancer	0.000424	0.00276	CcSEcCtD
Trazodone—Arrhythmia—Fluorouracil—colon cancer	0.000422	0.00276	CcSEcCtD
Trazodone—Alopecia—Fluorouracil—colon cancer	0.000418	0.00273	CcSEcCtD
Trazodone—HTR2A—vagina—colon cancer	0.000417	0.00772	CbGeAlD
Trazodone—Back pain—Irinotecan—colon cancer	0.000416	0.00271	CcSEcCtD
Trazodone—Anaemia—Vincristine—colon cancer	0.000408	0.00266	CcSEcCtD
Trazodone—ABCB1—epithelium—colon cancer	0.000406	0.00753	CbGeAlD
Trazodone—Agitation—Vincristine—colon cancer	0.000406	0.00265	CcSEcCtD
Trazodone—Photosensitivity—Methotrexate—colon cancer	0.000405	0.00264	CcSEcCtD
Trazodone—Polyuria—Methotrexate—colon cancer	0.000405	0.00264	CcSEcCtD
Trazodone—Ill-defined disorder—Irinotecan—colon cancer	0.000399	0.0026	CcSEcCtD
Trazodone—Anaemia—Irinotecan—colon cancer	0.000397	0.00259	CcSEcCtD
Trazodone—Vertigo—Vincristine—colon cancer	0.000396	0.00259	CcSEcCtD
Trazodone—Abdominal discomfort—Capecitabine—colon cancer	0.000396	0.00258	CcSEcCtD
Trazodone—Vision blurred—Fluorouracil—colon cancer	0.000388	0.00253	CcSEcCtD
Trazodone—Malaise—Irinotecan—colon cancer	0.000388	0.00253	CcSEcCtD
Trazodone—Vertigo—Irinotecan—colon cancer	0.000386	0.00252	CcSEcCtD
Trazodone—Syncope—Irinotecan—colon cancer	0.000385	0.00252	CcSEcCtD
Trazodone—Hypertension—Vincristine—colon cancer	0.000381	0.00249	CcSEcCtD
Trazodone—Anaemia—Fluorouracil—colon cancer	0.00038	0.00248	CcSEcCtD
Trazodone—Loss of consciousness—Irinotecan—colon cancer	0.000378	0.00247	CcSEcCtD
Trazodone—ABCB1—renal system—colon cancer	0.000377	0.00698	CbGeAlD
Trazodone—Photosensitivity reaction—Capecitabine—colon cancer	0.000377	0.00246	CcSEcCtD
Trazodone—Myalgia—Vincristine—colon cancer	0.000376	0.00245	CcSEcCtD
Trazodone—Weight increased—Capecitabine—colon cancer	0.000376	0.00245	CcSEcCtD
Trazodone—Visual disturbance—Methotrexate—colon cancer	0.000375	0.00245	CcSEcCtD
Trazodone—Weight decreased—Capecitabine—colon cancer	0.000373	0.00244	CcSEcCtD
Trazodone—Hypertension—Irinotecan—colon cancer	0.000371	0.00242	CcSEcCtD
Trazodone—Acute coronary syndrome—Capecitabine—colon cancer	0.000363	0.00237	CcSEcCtD
Trazodone—Cerebrovascular accident—Methotrexate—colon cancer	0.000363	0.00237	CcSEcCtD
Trazodone—Lethargy—Methotrexate—colon cancer	0.000363	0.00237	CcSEcCtD
Trazodone—Discomfort—Irinotecan—colon cancer	0.000362	0.00236	CcSEcCtD
Trazodone—Myocardial infarction—Capecitabine—colon cancer	0.000361	0.00236	CcSEcCtD
Trazodone—Oedema—Vincristine—colon cancer	0.00036	0.00235	CcSEcCtD
Trazodone—Jaundice—Capecitabine—colon cancer	0.000359	0.00234	CcSEcCtD
Trazodone—Confusional state—Irinotecan—colon cancer	0.000354	0.00231	CcSEcCtD
Trazodone—HTR2A—liver—colon cancer	0.000352	0.00651	CbGeAlD
Trazodone—Haematuria—Capecitabine—colon cancer	0.000351	0.00229	CcSEcCtD
Trazodone—Oedema—Irinotecan—colon cancer	0.000351	0.00229	CcSEcCtD
Trazodone—Myalgia—Fluorouracil—colon cancer	0.00035	0.00229	CcSEcCtD
Trazodone—Chest pain—Fluorouracil—colon cancer	0.00035	0.00229	CcSEcCtD
Trazodone—Hyperhidrosis—Vincristine—colon cancer	0.000348	0.00227	CcSEcCtD
Trazodone—Discomfort—Fluorouracil—colon cancer	0.000346	0.00226	CcSEcCtD
Trazodone—Shock—Irinotecan—colon cancer	0.000345	0.00225	CcSEcCtD
Trazodone—Anorexia—Vincristine—colon cancer	0.000343	0.00224	CcSEcCtD
Trazodone—Hyperhidrosis—Irinotecan—colon cancer	0.000339	0.00221	CcSEcCtD
Trazodone—Confusional state—Fluorouracil—colon cancer	0.000339	0.00221	CcSEcCtD
Trazodone—Hypotension—Vincristine—colon cancer	0.000337	0.0022	CcSEcCtD
Trazodone—Bradycardia—Capecitabine—colon cancer	0.000336	0.0022	CcSEcCtD
Trazodone—Oedema—Fluorouracil—colon cancer	0.000336	0.00219	CcSEcCtD
Trazodone—Anorexia—Irinotecan—colon cancer	0.000334	0.00218	CcSEcCtD
Trazodone—Ataxia—Methotrexate—colon cancer	0.000334	0.00218	CcSEcCtD
Trazodone—Hypoaesthesia—Capecitabine—colon cancer	0.000329	0.00215	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000328	0.00214	CcSEcCtD
Trazodone—Tachycardia—Fluorouracil—colon cancer	0.000328	0.00214	CcSEcCtD
Trazodone—Hypotension—Irinotecan—colon cancer	0.000328	0.00214	CcSEcCtD
Trazodone—Insomnia—Vincristine—colon cancer	0.000326	0.00213	CcSEcCtD
Trazodone—CYP3A4—liver—colon cancer	0.000325	0.00603	CbGeAlD
Trazodone—Paraesthesia—Vincristine—colon cancer	0.000323	0.00211	CcSEcCtD
Trazodone—HRH1—lymph node—colon cancer	0.000323	0.00598	CbGeAlD
Trazodone—CYP2D6—liver—colon cancer	0.00032	0.00593	CbGeAlD
Trazodone—Anorexia—Fluorouracil—colon cancer	0.00032	0.00209	CcSEcCtD
Trazodone—Visual impairment—Capecitabine—colon cancer	0.000318	0.00208	CcSEcCtD
Trazodone—Insomnia—Irinotecan—colon cancer	0.000317	0.00207	CcSEcCtD
Trazodone—ADRA2A—lymph node—colon cancer	0.000317	0.00587	CbGeAlD
Trazodone—Paraesthesia—Irinotecan—colon cancer	0.000315	0.00206	CcSEcCtD
Trazodone—Hypotension—Fluorouracil—colon cancer	0.000314	0.00205	CcSEcCtD
Trazodone—Decreased appetite—Vincristine—colon cancer	0.000313	0.00204	CcSEcCtD
Trazodone—ABCB1—lymphoid tissue—colon cancer	0.000313	0.0058	CbGeAlD
Trazodone—Dyspnoea—Irinotecan—colon cancer	0.000313	0.00204	CcSEcCtD
Trazodone—Somnolence—Irinotecan—colon cancer	0.000312	0.00204	CcSEcCtD
Trazodone—Fatigue—Vincristine—colon cancer	0.000311	0.00203	CcSEcCtD
Trazodone—ABCB1—digestive system—colon cancer	0.000309	0.00573	CbGeAlD
Trazodone—Tinnitus—Capecitabine—colon cancer	0.000308	0.00201	CcSEcCtD
Trazodone—Pain—Vincristine—colon cancer	0.000308	0.00201	CcSEcCtD
Trazodone—Constipation—Vincristine—colon cancer	0.000308	0.00201	CcSEcCtD
Trazodone—Flushing—Capecitabine—colon cancer	0.000307	0.002	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000306	0.002	CcSEcCtD
Trazodone—Decreased appetite—Irinotecan—colon cancer	0.000305	0.00199	CcSEcCtD
Trazodone—Insomnia—Fluorouracil—colon cancer	0.000304	0.00198	CcSEcCtD
Trazodone—Fatigue—Irinotecan—colon cancer	0.000302	0.00197	CcSEcCtD
Trazodone—Paraesthesia—Fluorouracil—colon cancer	0.000302	0.00197	CcSEcCtD
Trazodone—Domperidone—ABCB1—colon cancer	0.0003	0.216	CrCbGaD
Trazodone—Constipation—Irinotecan—colon cancer	0.0003	0.00196	CcSEcCtD
Trazodone—Pain—Irinotecan—colon cancer	0.0003	0.00196	CcSEcCtD
Trazodone—Dyspnoea—Fluorouracil—colon cancer	0.0003	0.00196	CcSEcCtD
Trazodone—Somnolence—Fluorouracil—colon cancer	0.000299	0.00195	CcSEcCtD
Trazodone—Chills—Capecitabine—colon cancer	0.000296	0.00194	CcSEcCtD
Trazodone—Arrhythmia—Capecitabine—colon cancer	0.000295	0.00193	CcSEcCtD
Trazodone—Abdominal discomfort—Methotrexate—colon cancer	0.000295	0.00192	CcSEcCtD
Trazodone—Gastrointestinal pain—Vincristine—colon cancer	0.000295	0.00192	CcSEcCtD
Trazodone—Decreased appetite—Fluorouracil—colon cancer	0.000292	0.00191	CcSEcCtD
Trazodone—Alopecia—Capecitabine—colon cancer	0.000292	0.00191	CcSEcCtD
Trazodone—Feeling abnormal—Irinotecan—colon cancer	0.000289	0.00189	CcSEcCtD
Trazodone—Pain—Fluorouracil—colon cancer	0.000287	0.00188	CcSEcCtD
Trazodone—Gastrointestinal pain—Irinotecan—colon cancer	0.000287	0.00187	CcSEcCtD
Trazodone—ABCB1—bone marrow—colon cancer	0.000285	0.00528	CbGeAlD
Trazodone—Abdominal pain—Vincristine—colon cancer	0.000285	0.00186	CcSEcCtD
Trazodone—Body temperature increased—Vincristine—colon cancer	0.000285	0.00186	CcSEcCtD
Trazodone—Flatulence—Capecitabine—colon cancer	0.000283	0.00185	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—colon cancer	0.000283	0.00185	CcSEcCtD
Trazodone—Dysgeusia—Capecitabine—colon cancer	0.000282	0.00184	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—colon cancer	0.000281	0.00183	CcSEcCtD
Trazodone—Back pain—Capecitabine—colon cancer	0.000278	0.00182	CcSEcCtD
Trazodone—Abdominal pain—Irinotecan—colon cancer	0.000277	0.00181	CcSEcCtD
Trazodone—Body temperature increased—Irinotecan—colon cancer	0.000277	0.00181	CcSEcCtD
Trazodone—Feeling abnormal—Fluorouracil—colon cancer	0.000277	0.00181	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—colon cancer	0.000274	0.00179	CcSEcCtD
Trazodone—ABCB1—vagina—colon cancer	0.000273	0.00506	CbGeAlD
Trazodone—Vision blurred—Capecitabine—colon cancer	0.000271	0.00177	CcSEcCtD
Trazodone—Tremor—Capecitabine—colon cancer	0.000269	0.00176	CcSEcCtD
Trazodone—Ill-defined disorder—Capecitabine—colon cancer	0.000267	0.00174	CcSEcCtD
Trazodone—Urticaria—Fluorouracil—colon cancer	0.000267	0.00174	CcSEcCtD
Trazodone—Anaemia—Capecitabine—colon cancer	0.000266	0.00174	CcSEcCtD
Trazodone—Body temperature increased—Fluorouracil—colon cancer	0.000266	0.00173	CcSEcCtD
Trazodone—Hypersensitivity—Vincristine—colon cancer	0.000265	0.00173	CcSEcCtD
Trazodone—Sweating—Methotrexate—colon cancer	0.000263	0.00171	CcSEcCtD
Trazodone—Haematuria—Methotrexate—colon cancer	0.000261	0.00171	CcSEcCtD
Trazodone—Malaise—Capecitabine—colon cancer	0.000259	0.00169	CcSEcCtD
Trazodone—Vertigo—Capecitabine—colon cancer	0.000258	0.00169	CcSEcCtD
Trazodone—Hypersensitivity—Irinotecan—colon cancer	0.000258	0.00169	CcSEcCtD
Trazodone—Asthenia—Vincristine—colon cancer	0.000258	0.00169	CcSEcCtD
Trazodone—Syncope—Capecitabine—colon cancer	0.000258	0.00168	CcSEcCtD
Trazodone—Palpitations—Capecitabine—colon cancer	0.000254	0.00166	CcSEcCtD
Trazodone—Loss of consciousness—Capecitabine—colon cancer	0.000253	0.00165	CcSEcCtD
Trazodone—Asthenia—Irinotecan—colon cancer	0.000252	0.00164	CcSEcCtD
Trazodone—Nefazodone—ABCB1—colon cancer	0.000249	0.18	CrCbGaD
Trazodone—Hypertension—Capecitabine—colon cancer	0.000248	0.00162	CcSEcCtD
Trazodone—Hypersensitivity—Fluorouracil—colon cancer	0.000248	0.00162	CcSEcCtD
Trazodone—Diarrhoea—Vincristine—colon cancer	0.000246	0.00161	CcSEcCtD
Trazodone—Arthralgia—Capecitabine—colon cancer	0.000245	0.0016	CcSEcCtD
Trazodone—Myalgia—Capecitabine—colon cancer	0.000245	0.0016	CcSEcCtD
Trazodone—Chest pain—Capecitabine—colon cancer	0.000245	0.0016	CcSEcCtD
Trazodone—Anxiety—Capecitabine—colon cancer	0.000244	0.00159	CcSEcCtD
Trazodone—Discomfort—Capecitabine—colon cancer	0.000242	0.00158	CcSEcCtD
Trazodone—Diarrhoea—Irinotecan—colon cancer	0.00024	0.00157	CcSEcCtD
Trazodone—Dry mouth—Capecitabine—colon cancer	0.00024	0.00156	CcSEcCtD
Trazodone—Dizziness—Vincristine—colon cancer	0.000238	0.00155	CcSEcCtD
Trazodone—Pruritus—Fluorouracil—colon cancer	0.000238	0.00155	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—colon cancer	0.000237	0.00155	CcSEcCtD
Trazodone—Confusional state—Capecitabine—colon cancer	0.000237	0.00155	CcSEcCtD
Trazodone—Oedema—Capecitabine—colon cancer	0.000235	0.00153	CcSEcCtD
Trazodone—Dizziness—Irinotecan—colon cancer	0.000232	0.00151	CcSEcCtD
Trazodone—Aripiprazole—ABCB1—colon cancer	0.000232	0.167	CrCbGaD
Trazodone—Shock—Capecitabine—colon cancer	0.000231	0.00151	CcSEcCtD
Trazodone—ABCB1—liver—colon cancer	0.00023	0.00427	CbGeAlD
Trazodone—Diarrhoea—Fluorouracil—colon cancer	0.00023	0.0015	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—colon cancer	0.000229	0.0015	CcSEcCtD
Trazodone—Tachycardia—Capecitabine—colon cancer	0.000229	0.0015	CcSEcCtD
Trazodone—Vomiting—Vincristine—colon cancer	0.000229	0.00149	CcSEcCtD
Trazodone—Rash—Vincristine—colon cancer	0.000227	0.00148	CcSEcCtD
Trazodone—Hyperhidrosis—Capecitabine—colon cancer	0.000227	0.00148	CcSEcCtD
Trazodone—Dermatitis—Vincristine—colon cancer	0.000227	0.00148	CcSEcCtD
Trazodone—Headache—Vincristine—colon cancer	0.000226	0.00147	CcSEcCtD
Trazodone—Anorexia—Capecitabine—colon cancer	0.000224	0.00146	CcSEcCtD
Trazodone—Vomiting—Irinotecan—colon cancer	0.000223	0.00146	CcSEcCtD
Trazodone—Dizziness—Fluorouracil—colon cancer	0.000222	0.00145	CcSEcCtD
Trazodone—Rash—Irinotecan—colon cancer	0.000221	0.00144	CcSEcCtD
Trazodone—Dermatitis—Irinotecan—colon cancer	0.000221	0.00144	CcSEcCtD
Trazodone—Chills—Methotrexate—colon cancer	0.000221	0.00144	CcSEcCtD
Trazodone—Headache—Irinotecan—colon cancer	0.00022	0.00143	CcSEcCtD
Trazodone—Hypotension—Capecitabine—colon cancer	0.000219	0.00143	CcSEcCtD
Trazodone—Alopecia—Methotrexate—colon cancer	0.000217	0.00142	CcSEcCtD
Trazodone—Nausea—Vincristine—colon cancer	0.000214	0.0014	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000214	0.0014	CcSEcCtD
Trazodone—Vomiting—Fluorouracil—colon cancer	0.000214	0.00139	CcSEcCtD
Trazodone—Insomnia—Capecitabine—colon cancer	0.000212	0.00139	CcSEcCtD
Trazodone—Rash—Fluorouracil—colon cancer	0.000212	0.00138	CcSEcCtD
Trazodone—Dermatitis—Fluorouracil—colon cancer	0.000212	0.00138	CcSEcCtD
Trazodone—Paraesthesia—Capecitabine—colon cancer	0.000211	0.00138	CcSEcCtD
Trazodone—Headache—Fluorouracil—colon cancer	0.00021	0.00137	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—colon cancer	0.00021	0.00137	CcSEcCtD
Trazodone—Dyspnoea—Capecitabine—colon cancer	0.000209	0.00137	CcSEcCtD
Trazodone—Nausea—Irinotecan—colon cancer	0.000208	0.00136	CcSEcCtD
Trazodone—Back pain—Methotrexate—colon cancer	0.000207	0.00135	CcSEcCtD
Trazodone—Decreased appetite—Capecitabine—colon cancer	0.000204	0.00133	CcSEcCtD
Trazodone—Fatigue—Capecitabine—colon cancer	0.000202	0.00132	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—colon cancer	0.000202	0.00132	CcSEcCtD
Trazodone—Pain—Capecitabine—colon cancer	0.000201	0.00131	CcSEcCtD
Trazodone—Constipation—Capecitabine—colon cancer	0.000201	0.00131	CcSEcCtD
Trazodone—Nausea—Fluorouracil—colon cancer	0.0002	0.0013	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—colon cancer	0.000199	0.0013	CcSEcCtD
Trazodone—Anaemia—Methotrexate—colon cancer	0.000198	0.00129	CcSEcCtD
Trazodone—Feeling abnormal—Capecitabine—colon cancer	0.000193	0.00126	CcSEcCtD
Trazodone—Malaise—Methotrexate—colon cancer	0.000193	0.00126	CcSEcCtD
Trazodone—Vertigo—Methotrexate—colon cancer	0.000192	0.00126	CcSEcCtD
Trazodone—Gastrointestinal pain—Capecitabine—colon cancer	0.000192	0.00125	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—colon cancer	0.000187	0.135	CrCbGaD
Trazodone—Urticaria—Capecitabine—colon cancer	0.000186	0.00122	CcSEcCtD
Trazodone—Abdominal pain—Capecitabine—colon cancer	0.000186	0.00121	CcSEcCtD
Trazodone—Body temperature increased—Capecitabine—colon cancer	0.000186	0.00121	CcSEcCtD
Trazodone—Chest pain—Methotrexate—colon cancer	0.000182	0.00119	CcSEcCtD
Trazodone—Myalgia—Methotrexate—colon cancer	0.000182	0.00119	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—colon cancer	0.000182	0.00119	CcSEcCtD
Trazodone—Discomfort—Methotrexate—colon cancer	0.00018	0.00118	CcSEcCtD
Trazodone—ABCB1—lymph node—colon cancer	0.000177	0.00327	CbGeAlD
Trazodone—Confusional state—Methotrexate—colon cancer	0.000176	0.00115	CcSEcCtD
Trazodone—Hypersensitivity—Capecitabine—colon cancer	0.000173	0.00113	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—colon cancer	0.000169	0.0011	CcSEcCtD
Trazodone—Asthenia—Capecitabine—colon cancer	0.000168	0.0011	CcSEcCtD
Trazodone—Anorexia—Methotrexate—colon cancer	0.000167	0.00109	CcSEcCtD
Trazodone—Pruritus—Capecitabine—colon cancer	0.000166	0.00108	CcSEcCtD
Trazodone—Hypotension—Methotrexate—colon cancer	0.000163	0.00107	CcSEcCtD
Trazodone—Diarrhoea—Capecitabine—colon cancer	0.000161	0.00105	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000159	0.00104	CcSEcCtD
Trazodone—Insomnia—Methotrexate—colon cancer	0.000158	0.00103	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—colon cancer	0.000157	0.00102	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—colon cancer	0.000156	0.00102	CcSEcCtD
Trazodone—Somnolence—Methotrexate—colon cancer	0.000155	0.00101	CcSEcCtD
Trazodone—Dizziness—Capecitabine—colon cancer	0.000155	0.00101	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—colon cancer	0.000152	0.000992	CcSEcCtD
Trazodone—Fatigue—Methotrexate—colon cancer	0.000151	0.000984	CcSEcCtD
Trazodone—Pain—Methotrexate—colon cancer	0.000149	0.000976	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—colon cancer	0.000149	0.108	CrCbGaD
Trazodone—Vomiting—Capecitabine—colon cancer	0.000149	0.000974	CcSEcCtD
Trazodone—Rash—Capecitabine—colon cancer	0.000148	0.000966	CcSEcCtD
Trazodone—Dermatitis—Capecitabine—colon cancer	0.000148	0.000965	CcSEcCtD
Trazodone—Headache—Capecitabine—colon cancer	0.000147	0.00096	CcSEcCtD
Trazodone—Quetiapine—ABCB1—colon cancer	0.000145	0.104	CrCbGaD
Trazodone—Feeling abnormal—Methotrexate—colon cancer	0.000144	0.00094	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—colon cancer	0.000143	0.000933	CcSEcCtD
Trazodone—Nausea—Capecitabine—colon cancer	0.000139	0.00091	CcSEcCtD
Trazodone—Urticaria—Methotrexate—colon cancer	0.000139	0.000906	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—colon cancer	0.000138	0.000902	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—colon cancer	0.000138	0.000902	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—colon cancer	0.000129	0.000841	CcSEcCtD
Trazodone—Asthenia—Methotrexate—colon cancer	0.000125	0.000819	CcSEcCtD
Trazodone—Clozapine—ABCB1—colon cancer	0.000125	0.0899	CrCbGaD
Trazodone—Pruritus—Methotrexate—colon cancer	0.000124	0.000807	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—colon cancer	0.00012	0.000781	CcSEcCtD
Trazodone—Dizziness—Methotrexate—colon cancer	0.000116	0.000754	CcSEcCtD
Trazodone—Vomiting—Methotrexate—colon cancer	0.000111	0.000725	CcSEcCtD
Trazodone—Rash—Methotrexate—colon cancer	0.00011	0.000719	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—colon cancer	0.00011	0.000719	CcSEcCtD
Trazodone—Headache—Methotrexate—colon cancer	0.000109	0.000715	CcSEcCtD
Trazodone—Nausea—Methotrexate—colon cancer	0.000104	0.000678	CcSEcCtD
